Archive | November, 2010

Heart Specialists Optimistic About New Cholesterol Drug Anacetrapib

Dr. Christopher Cannon, cardiologist, explains acacetrapib, an experimental drug by Merck that pushed the so-called good cholesterol HDL to off-the-charts levels while also dropping bad cholesterol LDL is renewing hopes for a novel way to lower heart risks. Anacetrapib works by inhibiting an enzyme, called CETP, that is involved in transforming particles of good cholesterol […]

Read the full story

Posted in Health Fitness News0 Comments